Utility of a Recombinant HSV-1 Vaccine Vector for Personalized Cancer Vaccines is a research paper published in Frontiers in Molecular Biosciences (2022). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 3P20GM103424-19S1
Louisiana Biomedical Research Network (LBRN)
National Institutes of Health
Grant: 5P30GM110760-02
GeneLab Core
National Institutes of Health
FWCI
1.01
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals